Related Experiment Video
Updated: Jan 16, 2026

05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.3K
HGBHAN: A Novel Framework for Microbe-Drug Interaction Prediction Using Heterogeneous Graphs and Bi-LSTM With
IEEE Journal of Biomedical and Health Informatics
|September 29, 2025
Summary
Predicting microbe-drug associations (MDAs) is crucial for drug discovery. Our HGBHAN model uses heterogeneous graphs and attention mechanisms for accurate predictions, outperforming existing methods on benchmark datasets.
Area of Science:
- Biomedical research
- Computational biology
- Drug discovery
Background:
- Predicting microbe-drug associations (MDAs) is vital for drug discovery and clinical interventions.
- Traditional lab methods are costly and slow; computational methods often miss complex network relationships and imbalanced data.
- Existing computational approaches for MDAs prediction face challenges with biological network complexity and data imbalance.
Purpose of the Study:
- To propose HGBHAN, a novel framework for robust microbe-drug association prediction.
- To leverage heterogeneous graphs and Bi-LSTM with hierarchical attention for enhanced MDA prediction.
- To improve the accuracy and scalability of computational methods for predicting microbe-drug associations.
Main Methods:
- Constructing a heterogeneous network integrating microbe/drug similarities and known associations.
- Employing Bi-LSTM modules with hierarchical attention for learning node embeddings.
- Utilizing residual connections to mitigate over-smoothing issues in graph neural networks.
Main Results:
- HGBHAN demonstrated superior performance across multiple evaluation metrics on three public datasets.
- The framework effectively captures multi-level structural and sequential dependencies in biological networks.
- The model achieved higher accuracy in predicting microbe-drug associations compared to existing methods.
Conclusions:
- HGBHAN provides a robust and effective framework for predicting microbe-drug associations.
- The proposed method addresses limitations of previous approaches, particularly regarding network heterogeneity and data imbalance.
- HGBHAN shows significant potential for accelerating drug discovery and optimizing clinical applications.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242

